Want to see WGRX full AI Analyst Report?
WGRX Stock Chart & Stats
$0.14
--
Market closed
$0.14
--
Day’s Range― - ―
52-Week Range$2.81 - $97.50
Previous CloseN/A
VolumeN/A
Average Volume (3M)28.82M
Market Cap
$7.83M
Enterprise Value$38.16M
Total Cash (Recent Filing)$51.73K
Total Debt (Recent Filing)$28.91M
Price to Earnings (P/E)―
Beta0.72
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,647,198
10 Day Avg. Volume1,367,507
30 Day Avg. Volume28,820,997
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.28
Price to Sales (P/S)1.22
P/FCF Ratio-2.61
Enterprise Value/Market Cap4.87
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit-3.93
Enterprise Value/Ebitda-0.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic Joint Venture Expands Patient ReachA 51% JV with Kare PharmTech meaningfully expands direct-to-patient distribution and telepharmacy scale. This durable channel access can create recurring revenue streams, lower customer acquisition costs, and accelerate commercialization of EinsteinRx and delivery services across a large patient base.
Proprietary AI And Blockchain Platform AssetsOwning AI-driven prescription routing plus blockchain-based data verification and biometric/drone delivery patents positions the company to capture value from tokenized patient data and secure supply chains. These technology and IP assets can create high switching costs and long-term differentiation in pharmacy infrastructure.
Near-term Liquidity Infusion From Convertible FinancingThe $16.9M cash proceeds materially improve near-term runway and reduced a legacy loan, lowering immediate default risk. Fresh capital gives the company time to execute strategic integrations and revenue initiatives, reducing the urgency of distressed asset sales while longer-term restructuring proceeds.
Bears Say
Severe Revenue And Margin DeteriorationSteep revenue declines and deeply negative gross and net margins indicate the current business cannot sustainably cover variable costs or overhead. Persistent cash burn erodes liquidity and forces reliance on external financing, limiting capacity for investment in growth and increasing solvency risk absent durable margin recovery.
Stressed Balance Sheet With Negative EquityNegative equity and material debt reduce financial flexibility and raise refinancing and covenant risks. This capital structure constrains strategic options, increases the cost of capital, and creates potential insolvency pathways if operating improvements or planned financings fail to restore positive equity over the medium term.
Potential Extreme Dilution And Governance ChangeA transaction that would transfer near-total economic control to new counterparties represents structural shareholder dilution and shifts strategic control. Such a governance overhaul can alter incentives, dilute existing holders' influence, and materially change execution priorities and capital allocation even if it stabilizes balance sheet metrics.
Wellgistics Health Inc News
WGRX FAQ
What was Wellgistics Health Inc’s price range in the past 12 months?
Wellgistics Health Inc lowest stock price was $2.81 and its highest was $97.50 in the past 12 months.
What is Wellgistics Health Inc’s market cap?
Wellgistics Health Inc’s market cap is $7.83M.
When is Wellgistics Health Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wellgistics Health Inc’s earnings last quarter?
Currently, no data Available
Is Wellgistics Health Inc overvalued?
According to Wall Street analysts Wellgistics Health Inc’s price is currently Overvalued.
Does Wellgistics Health Inc pay dividends?
Wellgistics Health Inc does not currently pay dividends.
What is Wellgistics Health Inc’s EPS estimate?
Wellgistics Health Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellgistics Health Inc have?
Wellgistics Health Inc has 2,647,198 shares outstanding.
What happened to Wellgistics Health Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Wellgistics Health Inc?
Currently, no hedge funds are holding shares in WGRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wellgistics Health Inc
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Technical Analysis
―
Prestige Consumer Healthcare
―
―
Synergy CHC
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
27.95% Insiders
17.09% Mutual Funds
― Other Institutional Investors
54.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---